📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Compound dominant-null heterozygosity in a family with RP1-related retinal dystrophy. (2022)

First Author: Buckley TMW

Attributed to: New genetic therapy approaches for inherited retinal diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ajoc.2022.101698

PubMed Identifier: 36393903

Publication URI: http://europepmc.org/abstract/MED/36393903

Type: Journal Article/Review

Volume: 28

Parent Publication: American journal of ophthalmology case reports

ISSN: 2451-9936